Skip to main content

Articles

Page 43 of 76

  1. Cisplatin is a platinum-based first-line drug for treating ovarian cancer. However, chemotherapy tolerance has limited the efficacy of cisplatin for ovarian cancer patients. Research has demonstrated that cisp...

    Authors: Xiao-Yu Yan, Xian-Zhi Qu, Long Xu, Si-Hang Yu, Rui Tian, Xin-Ru Zhong, Lian-Kun Sun and Jing Su
    Citation: Cancer Cell International 2020 20:128
  2. Kinesin superfamily proteins (KIFs) can transport membranous organelles and protein complexes in an ATP-dependent manner. Kinesin family member 15 (KIF15) is overexpressed in various cancers. However, the func...

    Authors: Lixian Ding, Bin Li, Xiaotong Yu, Zhongsheng Li, Xinglong Li, Shuwei Dang, Qiang Lv, Jiufeng Wei, Haixia Sun, Hongsheng Chen, Ming Liu and Guodong Li
    Citation: Cancer Cell International 2020 20:125
  3. LNK adaptor protein is a crucial regulator of normal hematopoiesis, which down-regulates activated tyrosine kinases at the cell surface resulting in an antitumor effect. To date, little studies have examined a...

    Authors: Jianxin Lv, Wei Yu, Yanan Zhang, Xinhua Cao, Lifei Han, Haolin Hu and Chenfei Wang
    Citation: Cancer Cell International 2020 20:124
  4. Kinesin superfamily (KIFs) has a long-reported significant influence on the initiation, development, and progress of breast cancer. However, the prognostic value of whole family members was poorly done. Our st...

    Authors: Tian-Fu Li, Hui-Juan Zeng, Zhen Shan, Run-Yi Ye, Tuck-Yun Cheang, Yun-Jian Zhang, Si-Hong Lu, Qi Zhang, Nan Shao and Ying Lin
    Citation: Cancer Cell International 2020 20:123
  5. Tenascin-C (TNC) is an extracellular matrix protein that is widely expressed in the stromal fibroblasts of various cancers. However, the roles of TNC in colorectal cancer (CRC) cells remain unclear.

    Authors: Zhaoting Yang, Chengye Zhang, Ying Feng, Mingji Quan, Yan Cui and Yanhua Xuan
    Citation: Cancer Cell International 2020 20:122
  6. As one of the many breast cancer subtypes, human epidermal growth factor receptor 2 (Her2)-positive breast cancer has higher invasiveness and poor prognosis, although the advent of anti-Her2 drugs has brought ...

    Authors: Chundi Gao, Jing Zhuang, Huayao Li, Cun Liu, Chao Zhou, Lijuan Liu, Fubin Feng, Changgang Sun and Jibiao Wu
    Citation: Cancer Cell International 2020 20:121
  7. Splicing factor SRSF3 is an oncogene and overexpressed in various kinds of cancers, however, the function and mechanism involved in colorectal cancer (CRC) remained unclear. The aim of this study was to explor...

    Authors: Ji-Lin Wang, Chun-Rong Guo, Tian-Tian Sun, Wen-Yu Su, Qiang Hu, Fang-Fang Guo, Lun-Xi Liang, Jie Xu, Hua Xiong and Jing-Yuan Fang
    Citation: Cancer Cell International 2020 20:120
  8. Circular RNAs (circRNAs) are identified to play an important role in many human cancers, such as glioblastoma. However, the potential mechanisms underlying the relationship between circRNAs and glioblastoma pa...

    Authors: Fei Zhu, Cheng Cheng, Hong qin, Hongsheng Wang and Hailong Yu
    Citation: Cancer Cell International 2020 20:118
  9. The carcinogenesis and progression of cervical cancer is a complex process in which numerous microRNAs are involved. The purpose of this study is to investigate the role of miR-125a-5p in progression of cervic...

    Authors: Qinxue Cao, Ning Wang, Lu Ren, Jun Tian, Shaoqin Yang and Hailing Cheng
    Citation: Cancer Cell International 2020 20:117
  10. The significance of long non-coding RNAs (lncRNAs) in mediating oxidative stress of cancers has been implicated recently. This study proposed a potential therapeutic target lncRNA growth arrest-specific transc...

    Authors: Wei Xu, Zeqiang Yan, Fen Hu, Wei Wei, Chao Yang and Zhihua Sun
    Citation: Cancer Cell International 2020 20:116
  11. Emerging studies have explored the prognostic value of MIR31HG in cancers, but its role remains elusive. Herein, we aimed to summarize the prognostic potential of MIR31HG in this study.

    Authors: Chao Tu, Xiaolei Ren, Jieyu He, Shuangqing Li, Lin Qi, Zhixi Duan, Wanchun Wang and Zhihong Li
    Citation: Cancer Cell International 2020 20:115
  12. Acute myeloid leukemia (AML) is a heterogeneous hematological disease. Our purpose of the research was to investigate the regulatory influence of long non-coding RNA (lncRNA) nuclear enriched abundant transcri...

    Authors: Song Feng, Na Liu, Xiaoguang Chen, Yufeng Liu and Jindou An
    Citation: Cancer Cell International 2020 20:112
  13. Glioblastoma (GBM) is a subclass of brain malignancy with unsatisfactory prognosis. MicroRNAs (miRNAs) are a group of non-coding RNAs (ncRNAs) that exert key function on tumorigenesis and tumor development.

    Authors: Xinli Zhao, Fazheng Shen, Jiwei Ma, Shupeng Zhao, Lei Meng, Xiangyang Wang, Shufeng Liang, Jianing Liang, Chaoshuai Hu and Xinzhong Zhang
    Citation: Cancer Cell International 2020 20:111
  14. A number of studies have demonstrated the critical role of long non-coding RNA gastric cancer high expressed transcript 1 (GHET1) in many cancers. This meta-analysis provides an evidence-based evaluation of th...

    Authors: Dingding Wang, Hong Zhang, Xiaolian Fang, Xue Zhang and Honggang Liu
    Citation: Cancer Cell International 2020 20:109
  15. Newly identified lncRNA zinc finger protein, FOG family member 2 antisense RNA 1 (ZFPM2-AS1) is identified as an oncogenic gene. However, the role of ZFPM2-AS1 in small cell lung cancer (SCLC) is poorly compre...

    Authors: Zhijun Yan, Qilian Yang, Min Xue, Sheng Wang, Weijun Hong and Xiwen Gao
    Citation: Cancer Cell International 2020 20:108
  16. Infections by both human oncoviruses, human Papillomaviruses (HPV) and Epstein–Barr virus (EBV) are very common in the adult human population and are associated with various malignancies. While HPV is generall...

    Authors: Ishita Gupta, Gheyath K. Nasrallah, Anju Sharma, Ayesha Jabeen, Maria K. Smatti, Hamda A. Al-Thawadi, Ali A. Sultan, Moussa Alkhalaf, Semir Vranic and Ala-Eddin Al Moustafa
    Citation: Cancer Cell International 2020 20:107

    The Correction to this article has been published in Cancer Cell International 2022 22:45

  17. Lung cancer is the leading cause of cancer-related mortality globally. Discovering effective biomarkers for early diagnosis and prognosis is important to reduce the mortality rate and ensure efficient therapy ...

    Authors: Jiaxing Sun, Tian Xie, Muhammad Jamal, Zhenbo Tu, Xinran Li, Yingjie Wu, Jingyuan Li, Qiuping Zhang and Xiaoxing Huang
    Citation: Cancer Cell International 2020 20:106
  18. Tumor progression and distant metastasis are the main causes of deaths in colorectal cancer (CRC) patients, and the molecular mechanisms in CRC metastasis have not been completely discovered.

    Authors: Wenping Lian, Huifang Jin, Jingjing Cao, Xinyu Zhang, Tao Zhu, Shuai Zhao, Sujun Wu, Kailu Zou, Xinyun Zhang, Mingliang Zhang, Xiaoyong Zheng and Mengle Peng
    Citation: Cancer Cell International 2020 20:105
  19. Colorectal cancer (CRC) is a malignant tumor, and the overall prognosis of patients with advanced CRC is still unsatisfactory. Circular RNAs (circRNAs) vesicle-associated membrane protein-associated protein A ...

    Authors: Xiaoyu Zhang, Yingying Xu, Kenji Yamaguchi, Jinping Hu, Lianbo Zhang, Jianfeng Wang, Jifeng Tian and Wanying Chen
    Citation: Cancer Cell International 2020 20:103
  20. This study aimed to screen osteosarcoma (OS) prognosis relevant genes for methylation dysregulation, and the functional mechanisms of FES overexpression in OS cells were investigated.

    Authors: Yang Zhao, Zhimeng Wang, Qian Wang, Liang Sun, Ming Li, Cheng Ren, Hanzhong Xue, Zhong Li, Kun Zhang, Dingjun Hao, Na Yang, Zhe Song, Teng Ma and Yao Lu
    Citation: Cancer Cell International 2020 20:102
  21. A number of JmjC domain-containing histone demethylases have been identified and biochemically characterized in mammalian models and humans. JMJD2A is a transcriptional co-factor and enzyme that catalyzes the ...

    Authors: Min Li, Jingmin Cheng, Yuan Ma, Heng Guo, Haifeng Shu, Haidong Huang, Yongqin Kuang and Tao Yang
    Citation: Cancer Cell International 2020 20:101
  22. Osteosarcoma (OS) is one of the most common types of primary bone tumors which poses negative effects on the bones of both young children and adolescents. LncRNA LINC00472 has been reported to be involved with...

    Authors: Jingwei Zhang, Jieyuan Zhang, Dong Zhang, Weifeng Ni, Haijun Xiao and Bizeng Zhao
    Citation: Cancer Cell International 2020 20:100
  23. Osteosarcoma is a malignant bone tumor. Increasing evidences have revealed that a disintegrin and metalloproteinase 10 (ADAM10) is implicated in tumor development. The main purpose of this study is to explore ...

    Authors: Quan Yuan, Honghao Yu, Jianhua Chen, Xiaoyu Song and Li Sun
    Citation: Cancer Cell International 2020 20:99
  24. Pancreatic ductal adenocarcinoma (PDAC) is a lethal human malignancy, and previous researches support the contribution of microRNA (miRNA) to cancer progression. MiR-122-5p is reported to participate in the re...

    Authors: Chen Dai, Yan Zhang, Zhihua Xu and Mengxian Jin
    Citation: Cancer Cell International 2020 20:98
  25. Activation of nuclear factor-kappa B (NF-κΒ) through DNA damage is one of the causes of tumor cell resistance to radiotherapy. Chromosome region 1 (CRM1) regulates tumor cell proliferation, drug resistance, an...

    Authors: Xuejiao Liu, Yiming Tu, Yifeng Wang, Di Zhou, Yulong Chong, Lin Shi, Guanzheng Liu, Xu Zhang, Sijin Wu, Huan Li, Shangfeng Gao, Mingshan Niu and Rutong Yu
    Citation: Cancer Cell International 2020 20:97
  26. Programmed death-ligand 1 (PD-L1) was the first identified ligand of programmed death-1 (PD-1). PD-1/PD-L1 interactions inhibit T cell-mediated immune responses, limit cytokine production, and promote tumor im...

    Authors: Jing Yang, Meilian Dong, Yifang Shui, Yue Zhang, Zhigang Zhang, Yin Mi, Xiaoxiao Zuo, Li Jiang, Ke Liu, Zheyan Liu, Xiaobin Gu and Yonggang Shi
    Citation: Cancer Cell International 2020 20:96
  27. Colitis-associated cancer (CAC) is a complication of inflammatory bowel disease (IBD) with a poor prognosis because it is often diagnosed in advanced stages with local progression or metastasis. Compared with ...

    Authors: Shuang Meng, Yingjie Li, Xiaozhen Zang, Zheng Jiang, Huahan Ning and Jing Li
    Citation: Cancer Cell International 2020 20:95
  28. Growing studies have focused on the role of microRNA-21 (miR-21) in glioma, thus our objective was to discuss the effect of M2 bone marrow-derived macrophage (BMDM)-derived exosomes (BMDM-Exos) shuffle miR-21 ...

    Authors: Fan Yang, Tiecheng Wang, Peng Du, Haitao Fan, Xushuai Dong and Hua Guo
    Citation: Cancer Cell International 2020 20:93
  29. Immunotherapies targeting programmed cell death 1 (PD-1) and programmed death-ligand 1 (PD-L1) have been approved for gastric cancer (GC) patients. However, a large proportion of patients with T-cell-inflamed ...

    Authors: Qianqian Ren, Peng Zhu, Hui Zhang, Tianhe Ye, Dehan Liu, Zhao Gong and Xiangwen Xia
    Citation: Cancer Cell International 2020 20:92
  30. Increasing evidence has proven that the γ-secretase complex plays significant roles in the carcinogenesis of malignancies. However, the independent effect of nicastrin (NCSTN), the largest constituent of the γ...

    Authors: Xicheng Wang, Xining Wang, Yunxiuxiu Xu, Maolin Yan, Wenxin Li, Jie Chen and Tao Chen
    Citation: Cancer Cell International 2020 20:91
  31. Breast cancer is the leading cause of cancer-related mortality in women worldwide. Long non-coding RNAs (lncRNAs) are of critical importance in tumor drug resistance. Herein, this study aims to determine the r...

    Authors: Jin Gao, Yuan Yuan, Lili Zhang, Shaorong Yu, Jianwei Lu, Jifeng Feng and Sainan Hu
    Citation: Cancer Cell International 2020 20:90

    The Retraction Note to this article has been published in Cancer Cell International 2021 21:40

  32. Extensive studies revealed that long non-coding RNAs (lncRNAs) could act as a regulator in tumors, including lung adenocarcinoma (LUAD). LncRNA FTX transcript, XIST regulator (FTX) has been reported to regulat...

    Authors: Xiaodong Huo, Huixing Wang, Bin Huo, Lei Wang, Kuo Yang, Jinhuan Wang, Lili Wang and Haitao Wang
    Citation: Cancer Cell International 2020 20:89
  33. Gastric cancer (GC) is the fifth most frequently diagnosed cancer and the third leading cause of cancer-related mortality. Lack of prognostic indicators for patient survival hinders GC treatment and survival.

    Authors: Chunmei Li, Ya Zheng, Ke Pu, Da Zhao, Yuping Wang, Quanlin Guan and Yongning Zhou
    Citation: Cancer Cell International 2020 20:88
  34. LncRNA NEAT1 has been identified as a tumour driver in many human cancers. However, the underlying mechanism of lncRNA NEAT1 in diffuse large B-cell lymphoma (DLBCL) progression is unclear.

    Authors: Chong-Sheng Qian, Ling-Jie Li, Hai-Wen Huang, Hai-Fei Yang and De-Pei Wu
    Citation: Cancer Cell International 2020 20:87
  35. Papillary carcinoma is an uncommon type of breast cancer. Additionally, patients with huge breast papillary carcinoma are extremely rare in clinical practice. To improve therapeutic effect on such patients, it...

    Authors: Xuelu Li, Bo Pan, Xiaoqing Song, Ning Li, Dongyi Zhao, Man Li and Zuowei Zhao
    Citation: Cancer Cell International 2020 20:86
  36. Currently, multiple circular RNAs (circRNAs) have been verified to act as essential regulators in the progression of gastric cancer (GC). We aimed to investigate the role of circ_0008035 in GC progression.

    Authors: Chang Li, Yuan Tian, Yun Liang and Qingchun Li
    Citation: Cancer Cell International 2020 20:84

    The Retraction Note to this article has been published in Cancer Cell International 2021 21:416

  37. Osteosarcoma is a highly aggressive bone tumor that most commonly affects children and adolescents. Treatment and outcomes for osteosarcoma have remained unchanged over the past 30 years. The relationship betw...

    Authors: Weifeng Hong, Hong Yuan, Yujun Gu, Mouyuan Liu, Yayun Ji, Zifang Huang, Junlin Yang and Liheng Ma
    Citation: Cancer Cell International 2020 20:83
  38. Recently, many emerging circular RNAs (circRNAs) have been studied in human malignancies, including gastric cancer (GC). Researches concerning cancers have revealed that aberrant expression of circRNAs play a ...

    Authors: Yan Ma, Xiliang Cong, Yiyun Zhang, Xin Yin, Ziyu Zhu and Yingwei Xue
    Citation: Cancer Cell International 2020 20:81
  39. Numerous circular RNAs (circRNAs) have been recognized as vital modulators of human malignancies, including glioma. Whereas, the functional role of circRNA Pituitary Homeo Box 1 (circPITX1) in the radioresista...

    Authors: Yongchang Guan, Zhi Cao, Jinghua Du, Tao Liu and Tingzhong Wang
    Citation: Cancer Cell International 2020 20:80
  40. Non-small-cell lung cancer (NSCLC) is one of the common cancers in the world. Circular RNA 0072083 (circ_0072083, circZFR) has been reported to be associated with the progression of NSCLC. In this study, we in...

    Authors: Huiping Li, Fangfang Liu and Wenjing Qin
    Citation: Cancer Cell International 2020 20:78
  41. This study aimed to comprehensively assess the diagnostic value of fibrinogen to prealbumin ratio (FPR) and gamma-glutamyl transpeptidase to platelet ratio (GPR) as single markers or in combination in patients...

    Authors: Li Huang, Zhuning Mo, Zuojian Hu, Linyan Zhang, Shanzi Qin, Xue Qin and Shan Li
    Citation: Cancer Cell International 2020 20:77
  42. Gastric cancer (GC) is a common cause of cancer-related mortality worldwide, and microRNAs (miRNAs) have been shown to play an important role in GC development. This study aims to explore the effect of microRN...

    Authors: Erdong Shen, Xin Wang, Xin Liu, Mingyue Lv, Liang Zhang, Guolian Zhu and Zhe Sun
    Citation: Cancer Cell International 2020 20:76

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here